Novel Orthobunyavirus Detected in Dairy Herds Across Southern Germany

Since mid-June 2026, dairy cattle in southern Germany and Switzerland have developed an acute syndrome marked by sharply reduced milk yield, diarrhea, fever, lethargy, and occasional mild respiratory signs. The outbreak moved quickly through affected farms in Baden-Württemberg, where more than 100 herds had been reported by the end of July. Herd-level illness was strikingly high, reaching 100% in some settings, yet no fatalities were reported. The pattern immediately suggested a contagious infectious process rather than isolated heat stress, even though environmental temperatures were high enough to complicate the early picture.

Classical bovine pathogens were systematically excluded before the culprit came into focus. Real-time reverse transcription PCR testing ruled out bluetongue virus, epizootic hemorrhagic disease virus, Schmallenberg virus, pestiviruses, bovine herpesvirus type 1, bovine ephemeral fever virus, West Nile virus, and Usutu virus. That narrow diagnostic funnel matters because the clinical syndrome overlapped with several vectorborne diseases already familiar to European veterinarians, yet none fit the outbreak once molecular testing was completed. The remaining suspicion centered on a biting-insect–borne virus, a plausible explanation given the summer timing and the rapid spread between herds.

Metagenomic Sequencing Identifies Shamonda virus

Investigators submitted serum and whole blood from 27 animals across four herds for deeper study. Because sample volume was limited, specimens were pooled by matrix and herd, yielding 16 pools for downstream analysis. Infectious virus was isolated from pooled samples from three herds on Vero cells and from one of those pools on BHK-21-BSR/5 cells, confirming that a viable agent was present rather than only residual nucleic acid.

Generic testing for the Simbu serogroup of Orthobunyavirus yielded positive results in 10 of 16 pools, with quantification cycle values ranging from 19.8 to 37.6. Every investigated farm contributed at least one positive pool, and positives came from both serum and whole blood. A second assay targeting the small segment of Simbu serogroup virus Sathuperi virus was also repeatedly positive, while a specific assay for Schmallenberg virus remained negative. Serology added another layer: 23 serum samples were positive by an SBV antibody ELISA, one was questionable, and three were negative. In a region where SBV immunity is already common, that serologic backdrop could easily have obscured the emergence of a related but distinct virus.

Metagenomic sequencing resolved the agent more definitively. Complete genome assembly recovered a full Shamonda virus sequence from the outbreak material, and phylogenetic analysis placed all three segments closest to the Nigeria Shamonda virus isolate Ib An 5550. Nucleotide identity reached 93% for the large and medium segments and 97% for the small segment. The genomic profile did not support an interlineage reassortant origin. Instead, the data pointed to a novel European clade of Shamonda orthobunyavirus closely related to African SHAV strains but distinct enough to raise immediate epidemiologic concern.

Why Existing Schmallenberg virus Immunity May Not Protect Herds

The most consequential finding is not simply that a new orthobunyavirus appeared, but that it did so in cattle populations already exposed to a related Simbu serogroup virus. High seroprevalence against SBV in the affected region did not prevent widespread clinical disease. The medium segment, which encodes the glycoproteins Gc and Gn, showed the key divergence. Those proteins are the major antigens of orthobunyaviruses, so sequence differences there offer a biologically credible explanation for why prior SBV immunity may not translate into meaningful cross-protection.

This creates a practical veterinary problem. If SHAV is transmitted by biting insects, as other Simbu serogroup viruses are, the new clade could circulate through the same seasonal window that already favors vector expansion in Central Europe. Alternating or cyclical dominance between SHAV and SBV is plausible, especially if vector abundance and herd immunity shift from year to year. In other regions where multiple vector-transmitted Simbu viruses circulate, such patterns have already been observed. Europe may be entering a similar phase, but the local trajectory will depend on surveillance, vector ecology, and the degree to which susceptible herds accumulate over time.

A second warning sign is the unresolved host range. Acute clinical disease has already been documented in cattle in Germany and Switzerland, yet the susceptibility of sheep, goats, and free-ranging ruminants remains uncertain. Multiple Simbu serogroup viruses have broader host ranges than cattle alone, and there is no reason to assume this clade will behave differently without direct evidence. Surveillance in pregnant animals deserves special attention because SHAV, like SBV, can cause severe fetal malformations when naïve dams are infected early in gestation. The outbreak therefore carries risks beyond transient adult illness and reduced milk production.

One immediate consequence is the need to look beyond cattle. Serologic and molecular surveillance in sheep, goats, and wildlife will determine whether the virus has already crossed species boundaries that were not captured in the initial dairy investigations.

Surveillance Priorities for the Coming Vector Season

The outbreak response now turns on three linked tasks: continued molecular testing, expanded serology, and vector identification. Detecting the local insect species responsible for transmission will be essential, because control measures cannot be designed around a virus alone. They must also account for the ecology that carries it between farms.

Longitudinal monitoring will determine whether SHAV becomes a recurring summer problem or an isolated introduction. The genomic evidence already shows that the virus is not merely a laboratory artifact or a mislabeled SBV variant. It is a real orthobunyavirus emergence event in a region where the livestock population has little reason to expect it. The next set of observations will reveal whether the first outbreak was the opening move of a broader established cycle, or the initial and most visible wave of a virus that has only just found its footing in Central Europe.


Reporting by Dr. Sarah Lin, MD, MPH for Medicine World Foundation, with additional data provided by CDC Emerging Infectious Diseases.